Next-Generation Sequencing – Webinars and Online Events

Over recent years, genomic sequencing of pathogens has emerged as a powerful tool to guide public health action by providing a deeper understanding of pathogen evolution, emerging variants and transmission dynamics. Oxford Nanopore Technologies offers an accessible, all-in-one sequencing platform that enables rapid, distributed and scalable genomic pathogen surveillance.

In this webinar, you will hear from leaders in the field of microbiology and infectious disease research, who will share their experiences in developing and implementing fast and accessible pathogen surveillance protocols with nanopore sequencing. The protocols presented in this webinar can be leveraged for targeted whole genome sequencing of different viral pathogens such as SARS-CoV-2 and monkeypox virus, as well as more broadly for the genomic characterization of known and novel viruses in an untargeted manner.

Attend this webinar to:
- Overcome key challenges when working with rare antigen-specific T cells
- Learn the key considerations when preparing samples for single-cell sequencing
- Gain insights into tumor single-cell sequencing results

With the genetics behind cancer being both diverse and complex, there are many genomic deviations that need to be detected and analyzed to further our understanding of the disease. Using nanopore sequencing, scientists can achieve the most comprehensive insight into cancer genomes. To explore this further, this symposium will bring together experts in cancer research, where they’ll cover how they are using the technology.

The speakers will discuss detecting missing structural variants, characterizing mutation patterns and how nanopore sequencing has advanced their research.

Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.

Speaking at The Landscape of Cancer Research 2022, Osama Al Dalahmah, PhD from Colombia University, presented his talk on paving the way to new mechanistic and therapeutic discoveries in glioblastoma.

In this webinar, Dr. Holz will discuss the background of cell-to-cell communication, highlighting studies and recent developments in the field as well as exploring the clinical implications of these studies on cancer biology and patient care.

The last twenty years have experienced extensive growth in the sequencing of cancer genomes, leading to a dramatically increased understanding of the role of genetic and epigenetic mutations in cancer.

In this webinar, we present a standardized workflow solution, including easy and automated nuclei extraction and isolation for reproducible single-nucleus sequencing analysis.

These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.

Watch this webinar to learn how to import data, identify discriminating variables as well as Visualize the results in different plot types such as PCA, heatmaps, box plots etc.